INSM - Insmed Inc
IEX Last Trade
76.45
0.120 0.157%
Share volume: 1,721,936
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$76.33
0.12
0.16%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-10-27 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-10-26 | 2024-02-22 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 1.053 B | 994.817 M | 1.656 B | 1.518 B | 1.439 B | 1.325 B | 1.330 B | 1.159 B | |
| Current Assets | 674.726 M | 632.165 M | 1.273 B | 1.129 B | 1.052 B | 926.576 M | 929.063 M | 758.722 M | |
| Inventories | 67.017 M | 66.276 M | 69.922 M | 71.317 M | 77.349 M | 77.923 M | 83.248 M | 82.957 M | |
| Other Current Assets | 23.360 M | 25.193 M | 25.468 M | 28.542 M | 26.360 M | 27.123 M | 24.179 M | 42.874 M | |
| Short Term Investments | 23.360 M | 25.193 M | 25.468 M | 28.542 M | 26.360 M | 27.123 M | 24.179 M | 42.874 M | |
| Total Receivables | 29.481 M | 27.401 M | 29.713 M | 30.523 M | 30.947 M | 35.579 M | 41.189 M | 37.162 M | |
| Current Cash | 554.868 M | 513.295 M | 1.148 B | 998.681 M | 917.768 M | 785.951 M | 780.447 M | 595.729 M | |
| Total Non-current Assets | 378.628 M | 362.652 M | 383.052 M | 388.654 M | 386.715 M | 398.297 M | 400.774 M | 400.373 M | |
| Property Plant Equipment | 53.946 M | 53.684 M | 56.491 M | 59.556 M | 62.113 M | 64.630 M | 65.384 M | 68.660 M | |
| Other Assets | 83.478 M | 80.408 M | 99.801 M | 104.341 M | 105.786 M | 114.149 M | 117.559 M | 116.005 M | |
| Intangible Assets | 71.283 M | 70.020 M | 68.756 M | 67.493 M | 66.230 M | 64.967 M | 63.704 M | 62.441 M | |
| Goodwill | 136.110 M | 136.110 M | 136.110 M | 136.110 M | 136.110 M | 136.110 M | 136.110 M | 136.110 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.053 B | 994.817 M | 1.656 B | 1.518 B | 1.439 B | 1.325 B | 1.330 B | 1.159 B | |
| Total liabilities | 1.009 B | 1.025 B | 1.568 B | 1.562 B | 1.595 B | 1.614 B | 1.662 B | 1.624 B | |
| Total current liabilities | 113.816 M | 137.654 M | 190.243 M | 187.984 M | 204.257 M | 196.728 M | 225.629 M | 420.860 M | |
| Accounts Payable | 31.144 M | 11.576 M | 50.461 M | 56.670 M | 55.699 M | 65.377 M | 65.393 M | 44.018 M | |
| Other liabilities | 69.984 M | 63.140 M | 208.502 M | 198.649 M | 57.561 M | 75.818 M | 87.745 M | 66.866 M | |
| Current long term debt | 212.000 K | 337.000 K | 1.217 M | 2.158 M | 2.445 M | 2.527 M | 2.610 M | 226.889 M | |
| Long term debt | 807.112 M | 807.478 M | 1.155 B | 1.161 B | 1.320 B | 1.329 B | 1.337 B | 1.122 B | |
| Other liabilities | 69.984 M | 63.140 M | 208.502 M | 198.649 M | 57.561 M | 75.818 M | 87.745 M | 66.866 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 44.241 M | -29.959 M | 87.951 M | -44.653 M | -155.745 M | -289.357 M | -331.923 M | -464.808 M | |
| Common stock | 119.602 M | 120.789 M | 132.820 M | 136.355 M | 137.553 M | 142.899 M | 144.925 M | 148.456 M | |
| Retained earnings | -2.405 B | -2.536 B | -2.697 B | -2.856 B | -3.101 B | -3.260 B | -3.446 B | -3.603 B |